“A new type of bone marrow transplant can cure sickle cell disease with only half of the donor’s cell proteins matching, according to new clinical trial results published in the New England Journal of Medicine.

…The procedure would greatly expand the pool of potential donors, in addition to costing less than one-quarter of the price of innovative gene therapies for the condition that have earned Food and Drug Administration approval in recent years.”

From Axios.